Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 24,726–24,750 of 27,380 studies, newest first · page 990 of 1096.

October 2002 16

  1. 2002-10-01

    Systematic detection and multidisciplinary care of delirium in older medical inpatients: a randomized trial

    ✓ Peer-reviewed Cognitive tests and assessment CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

    Key finding: Delirium is common and often goes undetected in older patients admitted to medical services. +3 more findings

  2. 2002-10-01

    Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease

    ✓ Peer-reviewed Cognitive tests and assessment Archives of general psychiatry

    Key finding: Reductions in cholinergic function occur in Alzheimer disease (AD) and dementia with Lewy bodies and correlate with cognitive decline. +3 more findings

  3. 2002-10-01

    Brief screening tests for dementia

    ✓ Peer-reviewed Cognitive tests and assessment Canadian journal of psychiatry. Revue canadienne de psychiatrie

    Key finding: We selected screening tests that met 2 criteria: 1) administration time of 10 minutes or less in studies including individuals with, and without, dementia; and 2) performance characteristics evaluated in at least 1 community or clinical sample of older adults. +3 more findings

  4. 2002-10-01

    Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein

    ✓ Peer-reviewed Risk genes beyond APOE Brain research

    Key finding: Cortical and hippocampal activities of AChE and ChAT were not different between transgenic mice and non-transgenic littermates regardless of the postnatal ages examined. +3 more findings

  5. 2002-10-01

    Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals

    ✓ Peer-reviewed Mild cognitive impairment Neurology

    Key finding: When comprehensive assessment procedures are employed, AD can be diagnosed with reasonably high accuracy in very mildly impaired individuals. +1 more finding

  6. 2002-10-01

    Rates of progression in mild cognitive impairment and early Alzheimer's disease

    ✓ Peer-reviewed Mild cognitive impairment Neurology

    Key finding: The lack of effective predictors of the rate of dementia progression extends to the very earliest stages of the disease, including what is often called MCI.

  7. 2002-10-01
  8. 2002-10-01

    Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank

    ✓ Peer-reviewed Lewy body dementia Alzheimer disease and associated disorders

    Key finding: AD was the most frequent pathologic finding (77%), followed by LBD (26%), VaD (18%), HS (13%), and FTD (5%). +4 more findings

  9. 2002-10-01

    Frontotemporal dementia: patient characteristics, cognition, and behaviour

    ✓ Peer-reviewed Digital health tools International journal of geriatric psychiatry

    Key finding: The average age at onset of first symptoms was 57.8 years. +2 more findings

  10. 2002-10-01

    Delirium superimposed on dementia: a systematic review

    ✓ Peer-reviewed How common it is Journal of the American Geriatrics Society

    Key finding: To date, only one reported study systematically identified associated factors and interventions for delirium superimposed on dementia, but several studies examining outcomes have found that adverse events are associated with delirium in persons with dementia, including accelerated and long-term cognitive and functional decline, need for institutionalization, rehospitalization, and increased mortality.

  11. 2002-10-01

    Rural families caring for a relative with dementia: barriers to use of formal services

    ✓ Peer-reviewed Disparities Social science & medicine (1982)

    Key finding: Planning for the care of increasing numbers of elderly persons with dementia has become an urgent health services concern in Canada and elsewhere, yet little is known about the challenges of providing appropriate dementia care in rural areas. +4 more findings

  12. 2002-10-01

    Dementia caregiver intervention research: in search of clinical significance

    ✓ Peer-reviewed Caregiving The Gerontologist

    Key finding: Although many studies have reported small to moderate statistically significant effects on a broad range of outcomes, only a small proportion of these studies achieved clinically meaningful outcomes.

  13. 2002-10-01

    Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease

    ✓ Peer-reviewed Caregiving Journal of neurology, neurosurgery, and psychiatry

    Key finding: Change in eating behaviour was significantly more common in both of the frontotemporal dementia groups than in Alzheimer's disease. +1 more finding

  14. 2002-10-01

    The overlap of amyotrophic lateral sclerosis and frontotemporal dementia

    ✓ Peer-reviewed Getting a diagnosis Neurology

    Key finding: An additional five patients had prominent fasciculations and six other patients had trouble swallowing but all had normal results on EMG studies.

  15. 2002-10-01
  16. 2002-10-01

    Apolipoprotein E, amyloid, and Alzheimer disease

    ✓ Peer-reviewed Genetics Molecular interventions

    Key finding: Despite important inroads into the molecular pathology of Alzheimer disease, effective long-term treatment for the condition remains elusive. +2 more findings

September 2002 9

  1. 2002-09-20

    Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling

    ✓ Peer-reviewed Disease mechanisms Proceedings of the National Academy of Sciences of the United States of America

    Key finding: These observations suggest that Alphabeta acts directly on the pathways involved in the formation of late LTP and agents that enhance the cAMP/PKA/CREB-signaling pathway have potential for the treatment of AD.

  2. 2002-09-16

    Deaths: leading causes for 2000

    ✓ Peer-reviewed Disparities PubMed

    Key finding: In 2000 the 10 leading causes of death were (in rank order) Diseases of heart; Malignant neoplasms; Cerebrovascular diseases; Chronic lower respiratory diseases; Accidents (unintentional injuries); Diabetes mellitus; Influenza and pneumonia; Alzheimer's disease; Nephritis, nephrotic syndrome and nephrosis; and Septicemia and accounted for nearly 80 percent of all deaths occurring in the United States. +3 more findings

  3. 2002-09-13

    The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection

    ✓ Peer-reviewed Inflammation and the immune system The Journal of infectious diseases

    Key finding: Latent reservoirs of human immunodeficiency virus (HIV) present significant challenges for eradicating HIV from infected persons, particularly reservoirs in the brain established during acute infection. +2 more findings

  4. 2002-09-01

    The accuracy of medicare claims data in identifying Alzheimer's disease

    ✓ Peer-reviewed Costs and economics Journal of clinical epidemiology

    Key finding: The data indicate that at least 3 consecutive years of physician supplier and physician outpatient claim files should be used to identify Medicare beneficiaries with AD using Medicare claims.

  5. 2002-09-01
  6. 2002-09-01

    Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4

    ✓ Peer-reviewed Drug development The Journal of pharmacology and experimental therapeutics

    Key finding: These findings identify a novel neuroprotective/neurotrophic function of GLP-1 and suggest that such peptides may have potential for halting or reversing neurodegenerative processes in CNS disorders, such as Alzheimer's disease, and in neuropathies associated with type 2 diabetes mellitus.

  7. 2002-09-01

    A role for local inflammation in the formation of drusen in the aging eye

    ✓ Peer-reviewed Brain scans and imaging American journal of ophthalmology

    Key finding: The results support a role for local inflammation in drusen biogenesis, and suggest that it is analogous to the process that occurs in other age-related diseases, such as Alzheimer's disease and atherosclerosis, where accumulation of extracellular plaques and deposits elicits a local chronic inflammatory response that exacerbates the effects of primary pathogenic stimuli. +2 more findings

  8. 2002-09-01

    Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71

    ✓ Peer-reviewed Genetics Journal of neurochemistry

    Key finding: In particular, it has been shown that protein modification by reactive oxygen species (ROS) occurs to a greater extent in AD than in control brain, suggesting a possible role for oxidation-related decrease in protein function in the process of neurodegeneration. +3 more findings

  9. 2002-09-01

    Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death

    ✓ Peer-reviewed Genetics Neurobiology of aging

    Key finding: Abeta(1-42) addition to synaptosomes also results in HNE binding to Glt-1, thereby coupling increased Abeta(1-42) in AD brain to increased lipid peroxidation and its sequelae and possibly explaining the mechanism of glutamate transport inhibition known in AD brain. +3 more findings

Browse the library by subject, with the full score breakdown →